Re: Email From Matt Pfeffer
in response to
by
posted on
Jun 17, 2012 01:35PM
Edit this title from the Fast Facts Section
That's alright,Rak, at least you tried.The thought of asking the company if the trials were blind,never even occurred to me.From MannKind's point of view it is probably beneficial if we think both trials are blind.Then we won't be bugging them for early trial results.I still contend that we won't have to.If Al puts more money into the company or a partnership is signed,we will then know that the trials are going well.